The Resource Current issues in the development of atypical antipsychotic drugs, edited by J.A. Lieberman and W.W. Fleischhacker

Current issues in the development of atypical antipsychotic drugs, edited by J.A. Lieberman and W.W. Fleischhacker

Label
Current issues in the development of atypical antipsychotic drugs
Title
Current issues in the development of atypical antipsychotic drugs
Statement of responsibility
edited by J.A. Lieberman and W.W. Fleischhacker
Contributor
Subject
Genre
Language
eng
Member of
Cataloging source
MMU
Illustrations
illustrations
Index
no index present
Literary form
non fiction
Nature of contents
bibliography
http://library.link/vocab/relatedWorkOrContributorDate
  • 1948-
  • 1994 :
http://library.link/vocab/relatedWorkOrContributorName
  • Lieberman, Jeffrey A.
  • Fleischhacker, W. W.
  • Royal College of Psychiatrists
  • Collegium Internationale Neuro-psychopharmacologicum
Series statement
British journal of psychiatry,
Series volume
suppl. 29, vol. 168, May 1996
http://library.link/vocab/subjectName
  • Antidepressive Agents, Second-Generation
  • Antipsychotic Agents
Label
Current issues in the development of atypical antipsychotic drugs, edited by J.A. Lieberman and W.W. Fleischhacker
Instantiates
Publication
Note
"Articles ... based on information originally presented in a symposium, Current issues in the Development of Atypical Antipsychotics, at the XIX Collegium Internationale Neuro-Psychopharmacologicum, June 1994, in Washington, DC."--p. 7
Bibliography note
Includes bibliographical references
Carrier category
volume
Carrier category code
  • nc
Carrier MARC source
rdacarrier
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
Perspectives on treatment needs in schizophrenia -- Treatment of negative symptoms: pharmacological and methodological issues -- Pre-clinical pharmacology of atypical antipsychotic drugs: a selective review -- Extrapyramidal syndromes and new antipsychotic drugs: findings in patients and non-human primate models -- Positron emission tomography studies of in-vivo binding characteristics of atypical antipsychotic drugs. Review of D2 and 5-HT2 receptor occupancy studies and clinical response -- ICI 204,636: a new atypical antipsychotic drug
Control code
34706249
Dimensions
25 cm
Extent
56 pages
Media category
unmediated
Media MARC source
rdamedia
Media type code
  • n
Other physical details
illustrations
Label
Current issues in the development of atypical antipsychotic drugs, edited by J.A. Lieberman and W.W. Fleischhacker
Publication
Note
"Articles ... based on information originally presented in a symposium, Current issues in the Development of Atypical Antipsychotics, at the XIX Collegium Internationale Neuro-Psychopharmacologicum, June 1994, in Washington, DC."--p. 7
Bibliography note
Includes bibliographical references
Carrier category
volume
Carrier category code
  • nc
Carrier MARC source
rdacarrier
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
Perspectives on treatment needs in schizophrenia -- Treatment of negative symptoms: pharmacological and methodological issues -- Pre-clinical pharmacology of atypical antipsychotic drugs: a selective review -- Extrapyramidal syndromes and new antipsychotic drugs: findings in patients and non-human primate models -- Positron emission tomography studies of in-vivo binding characteristics of atypical antipsychotic drugs. Review of D2 and 5-HT2 receptor occupancy studies and clinical response -- ICI 204,636: a new atypical antipsychotic drug
Control code
34706249
Dimensions
25 cm
Extent
56 pages
Media category
unmediated
Media MARC source
rdamedia
Media type code
  • n
Other physical details
illustrations

Library Locations

    • J. Otto Lottes Health Sciences LibraryBorrow it
      1 Hospital Dr, Columbia, MO, 65201, US
      38.939544 -92.328377
Processing Feedback ...